Intelligence Platform
Patents
Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8653243
Pertussis antibodies and uses thereof
granted patentUS 8653034
Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives
granted patentUS 8652366
Aerosol-mediated particle synthesis
granted patentUS 8648102
Compounds for treatment of cell proliferative diseases
granted patentUS 8637503
Phenothiazine enantiomers as agents for the prevention of bone loss
granted patentUS 8637675
Inhibitors of proliferation and activation of signal transducer and activators of transcri
granted patentUS 8632510
Nanochanneled device and related methods
granted patentUS 8629119
Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders
granted patentUS 8618074
GPCR enhanced neuroprotection to treat brain injury
granted patentUS 8618324
Composition and method for making oligo-benzamide compounds
granted patentUS 8618167
Methods of attenuating cognitive deficits with sulfonyl fluorides
granted patentUS 8617538
Mesodermal-like cell population for treating ischemia in mammals
granted patentUS 8613944
Compositions and methods for separating tissue
granted patentUS 8614082
Attenuation of encephalitogenic alphavirus and uses thereof
granted patentUS 8609067
Method of measuring propulsion in lymphatic structures
granted patentUS 8604074
Pro-neurogenic compounds
granted patentUS 8597616
Dry powder drug delivery formulations, methods of use, and devices therefore
granted patentUS 8592384
Micro-RNA's that regulate muscle cells
granted patentUS 8586553
Therapies for cancer using RLIP76
granted patentUS 8586046
Methods and compositions for mycoplasma pneumoniae exotoxins
granted patentUS 8580845
Functionalized expanded porphyrins
granted patentUS 8580738
Methods for treatment of reperfusion injury and other cardiac conditions
granted patentUS 8563595
Treatment of cancer with complex organic-inorganic pigment compositions
granted patentUS 8563022
Particles for cell targeting
granted